Balyasny Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,581
| Closed | -$233K | – | 2284 |
|
|
2023
Q4 | $233K | Sell |
22,581
-3,694
| -14% | -$38.1K | ﹤0.01% | 1701 |
|
|
2023
Q3 | $207K | Buy |
+26,275
| New | +$207K | ﹤0.01% | 1547 |
|
|
2022
Q4 | – | Sell |
-15,930
| Closed | -$208K | – | 2599 |
|
|
2022
Q3 | $208K | Buy |
+15,930
| New | +$208K | ﹤0.01% | 1820 |
|
|
2021
Q3 | – | Sell |
-78,527
| Closed | -$2.08M | – | 1960 |
|
|
2021
Q2 | $2.08M | Buy |
78,527
+35,072
| +81% | +$930K | 0.01% | 881 |
|
|
2021
Q1 | $1.35M | Buy |
+43,455
| New | +$1.35M | 0.01% | 987 |
|